Skip to main content
Fig. 5 | BMC Medical Imaging

Fig. 5

From: Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies

Fig. 5

A Decision curve analysis (DCA) for the models for predicting csPCa in the development cohort. B DCA for the models for predicting csPCa in validation cohort 1. C DCA for the models for predicting csPCa in validation cohort 2. csPCa = Clinically significant prostate cancer; DCA = Decision curve analysis

Back to article page